Unlocking nature's hidden treasures: Actinomycetota's arsenal of potent antiviral compounds against human viral infections
- 5 August 2025
- journal article
- review article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 208, 107953
Abstract
No abstract availableKeywords
Funding Information
- Universiti Malaya
This publication has 135 references indexed in Scilit:
- Challenges in the treatment and prevention of monkeypox infection; A comprehensive reviewActa Tropica, 2023
- Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countriesGeroScience, 2022
- Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico studyPharmacological Reports, 2021
- Family Coronaviridae2017
- Antibacterial, Anticancer and Neuroprotective Activities of Rare Actinobacteria from Mangrove Forest SoilsIndian Journal of Microbiology, 2016
- Influenza Virus: A Brief OverviewProceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2012
- Antiviral agents from natural sourcesPharmacology & Therapeutics, 1980
- Inhibition of influenza a virus replication by rifampicin and selenocystamineJournal of Medical Virology, 1980
- The effect of phleomycin on poliovirus RNA replicationVirology, 1970
- Valinomycin I, XXVII. Mitteil. über Antibiotica aus ActinomycetenEuropean Journal of Inorganic Chemistry, 1955